Freezing Instead of Cutting: FDA-Required Study of Breast Cancer Cryoablation Enrolls First U.S. Patients

Instead of removing small, low-risk breast tumors, a needle-based device freezes them in place. Its maker has started the larger U.S. study the FDA required, which will follow 400 older women for five years to see how often cancer returns.